Vasodilating Mechanisms of Testosterone

Abstract

The increased incidence of cardiovascular disease in man compared with premenopausal women suggests an unfavourable effect of male sex hormone testosterone on the cardiovascular system. However, numerous clinical and epidemiological studies reported a controversial relationship between testosterone and cardiovascular disease. Furthermore, an increasing amount of evidence indicate that testosterone can exert acute vasorelaxing effects, via non-genomic mechanisms. These effects involve primarily the vascular smooth muscle, without requiring the presence of endothelium, although an endothelial contribution is apparent in some studies. To date, the mechanism behind the vasodilatory action of testosterone is still under debate and might be through either activation of K⁺ channels or blockade of Ca²⁺ channels in vascular muscle cells. The purpose of this article is to review the evidence regarding the vasodilating effect of testosterone as well as its mechanism of action.

Key words

testosterone - vasodilation - vascular smooth muscle - nongenomic effects

References

• 1 Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.  Circ Res. 1999;  84 813-819
• 2 Belfort MA, Saade GR, Suresh M, Vedernikov YP. Effects of estadiol-17 beta and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women.  Am J Obstet Gynecol. 1996;  174 246-253
• 3 Berridge MJ. Inositol triphosphate and diacylglycerol: two interacting second messengers.  Annu Rev Biochem. 1987;  56 159-193
• 4 Cho JJ, Cadet P, Salamon E, Mantione K, Stefano GB. The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men.  Med Sci Monit. 2003;  9 RA63-8
• 5 Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo.  Circulation. 1996;  94 2614-2619
• 6 Costarella CE, Stallone JN, Rutecki GW. et al . Testosterone causes direct relaxation of rat thoracic aorta.  J Pharmacol Exp Ther. 1996;  277 34-39
• 7 Crews JK, Khalil RA. Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction.  Arterioscler Thromb Vasc Biol. 1999a;  19 1034-1040
• 8 Crews JK, Khalil RA. Gender-specific inhibition of Ca²⁺ entry mechanisms of arterial vasoconstriction by sex hormones.  Clin Exp Pharmacol Physiol. 1999b;  26 707-715
• 9 Darkow DJ, Lu L, White RE. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP.  Am J Physiol. 1997;  272 ((6 Pt 2)) H2765-73
• 10 Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel.  Am J Physiol Heart Circ Physiol. 2001;  281 H1720-H1727
• 11 Ding AQ, Stallone JN. Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K⁺ channel activation.  J Appl Physiol. 2001;  91 2742-2750
• 12 Duell PB, Bierman EL. The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men.  Arch Intern Med. 1990;  150 2317-2320
• 13 English KM, Jones RD, Channer KS, Jones TH. The coronary vasodilatory effect of testosterone is mediated at the cell membrane, not by an intracellular receptor.  J Endocrinol. 2000c;  164 P296
• 14 English KM, Jones RD, Jones TH, Jones TH, Morice AH, Channer KS. Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries.  Horm Metab Res. 2001;  33 645-652
• 15 English KM, Jones RD, Jones TH, Morice AH, Channer KS. Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone.  Clin Sci. 2000d;  99 77-82
• 16 English KM, Jones RD, Jones TH, Morice AH, Channer KS. Testosterone acts as a coronary vasodilator by a calcium antagonistic action.  J Endocrinol Invest. 2002;  25 455-458
• 17 English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.  Eur Heart J. 2000a;  21 890-894
• 18 English KM, Steeds R, Jones TH, Channer KS. Testosterone and coronary heart disease: is there a link?.  QJM. 1997a;  90 787-791
• 19 English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina.  Circulation. 2000b;  102 1906-1911
• 20 Fausett MB, Belfort MA, Nanda R. The effects of sex steroids on human umbilical artery and vein.  J Soc Gynecol Investig.. 1999;  6 27-31
• 21 Goetz CJ, Thatte HS, Prabhakar P, Cho MR, Michel T, Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide syntase.  Proc Natl Acad Sci USA. 1999;  96 2788-2793
• 22 Gul H, Yildiz O, Seyrek M, Un I. Protein Kinase C Inhibition May Contribute To Testosterone Induced Relaxation In Human Internal Mammary Artery.  , 9th Balkan Military Medical Committee, Abstract book 2004;  , page: 422 , P-291
• 23 Hall J, Jones RD, Jones TH, Channer KS, Peers C. Selective inhibition of L-type Ca²⁺ channels in a7r5 cells by physiological levels of testosterone.  Endocrinology.. 2006;  147 2675-2680
• 24 Han G, Yu X, Lu L, Li S, Ma H, Zhu S, Cui X, White RE. Estrogen receptor alpha mediates acute potassium channel stimulation in human coronary artery smooth muscle cells.  J Pharmacol Exp Ther. 2006;  316 1025-1030
• 25 Harder DR, Belardinelli L, Sperelakis N, Rubio R, Berne RM. Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries.  Circ Res. 1979;  44 176-182
• 26 Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide syntase by estradiol in human aortic endothelial cells.  FEBS Lett. 1995;  360 291-293
• 27 Honda H, Unemoto T, Kogo H. Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats.  Hypertension. 1999;  34 1232-1236
• 28 Hromadova M, Hacik T, Malatinsky E, Riecansky I. Alterations of lipid metabolism in men with hypotestosteronemia.  Horm Metab Res. 1991a;  23 392-394
• 29 Hromadova M, Hacik T, Malatinsky E, Sklovsky A, Cervenakov J, Labady F. Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment.  Int Urol Nephrol. 1991b;  23 69-75
• 30 Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS. Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action.  J Cardiovasc Pharmacol. 2002;  39 814-823
• 31 Jones RD, Jones TH, Channer KS. The influence of testosterone upon vascular reactivity.  Eur J Endocriol. 2004;  151 29-37
• 32 Jones RD, Pugh PJ, Hall J, Channer KS, Jones TH. Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse.  Eur J Endocrinol.. 2003b;  148 111-120
• 33 Jones RD, Pugh PJ, Jones TH, Channer KS. Vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?.  Br J Pharmacol. 2003c;  138 733-744
• 34 Jones RD, Rowell KO, Pugh PJ, Adam IR, Vaughan R, Rocco G. Testosterone-induced vasodilatation of isolated human mesenteric and pulmonary resistance arteries is independent of the vascular endothelium.  Endocr Abstracts. 2003a;  7 P66
• 35 Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship.  J Hypertens. 1988;  6 329-332
• 36 Khaw KT, Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men.  Arterioscler Thromb. 1991;  11 489-494
• 37 Kunz L, Ramsch R, Krieger A, Young KA, Dissen GA, Stouffer RL, Ojeda SR, Mayerhofer A. Voltage-dependent K⁺ channel acts as sex steroid sensor in endocrine cells of the human ovary.  J Cell Physiol. 2006;  167-174
• 38 Littleton-Kearney M, Hurn PD. Testosterone as a modulator of vascular behavior.  Biol Res Nurs. 2004;  5 276-285
• 39 Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension.  Ann Intern Med. 1987;  107 158-161
• 40 Murphy JG, Khalil RA. Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone.  J Pharmacol Exp Ther. 1999;  291 44-52
• 41 Perusquia M, Hernandez R, Morales MA, Campos MG, Villalon CM. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta.  Gen Pharmacol. 1996;  27 181-185
• 42 Raymond V, Leung PC, Labrie F. Stimulation by prostaglandin F₂ alpha of phosphatidic acid-phosphatidilinositol turnover in rat luteal cells.  Biochem Biophys Res Commun. 1983;  116 39-46
• 43 Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica PL, Bonfigli B, Volpe M, Chierchia SL. Acute anti-ischemic effect of testosterone in men with coronary artery disease.  Circulation. 1999;  99 1666-1670
• 44 Sato K, Kanatsuka H, Sekiguchi N, Akai K, Wang Y, Sugimura A, Kumagai T, Komaru T, Shirato K. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart.  Cardiovasc Res. 1994;  28 1780-1786
• 45 Scheuer J, Malhotra A, Schaible TF, Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts.  Circ Res. 1987;  61 12-19
• 46 Scragg JL, Jones RD, Channer KS, Jones TH, Peers C. Testosterone is a potent inhibitor of L-type calcium channels.  Biochem Biophys Res Comm. 2004;  318 503-506
• 47 Shimizu S, Yokoshiki H, Sperelakis N, Paul RJ. Role of voltage-dependent and Ca(2+)-activated K(+) channels on the regulation of isometric force in porcine coronary artery.  J Vasc Res. 2000;  37 16-25
• 48 Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones.  Eur J Endocrinol. 2003;  148 281-292
• 49 Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen thearpy and cardiovascular disease. Ten-year follow-up from the nurses’ health study.  N Eng L Med. 1991;  325 756-762
• 50 Teoh H, Quan A, Leung SW, Man RY. Differantial effects of 17beta-estradiol and testosteone on the contractile responses of porcine coronary arteries.  Br J Pharmacol. 2000;  129 1301-1308
• 51 Tep-areenan P, Kendall DA, Randall MD. Mechanisms of vasorelaxation to testosterone in rat aorta.  Eur J Pharmacol. 2003;  465 125-132
• 52 Tep-areenan P, Kendall DA, Randall MD. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels.  Br J Pharmacol. 2002;  135 735-740
• 53 Thompson J, Khalil RA. Gender differences in the regulation of vascular tone.  Clin Exp Pharmacol Physiol. 2003;  30 1-15
• 54 Tosun M, Paul RJ, Rapoport RM. Intracellular Ca²⁺ elevation and contraction due to prostaglandin F₂ alpha in rat aorta.  Eur J Pharmacol. 1997;  340 203-208
• 55 Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit.  Science. 1999;  285 1929-1931
• 56 Webb CM, Adamson DL, de Zeigler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease.  Am J Cardiol. 1999;  83 437-439
• 57 Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.  Circulation. 1999;  100 1690-1696
• 58 White RE, Darkow DJ, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.  Circ Res. 1995;  77 936-942
• 59 White RE, Han G, Maunz M, Dimitropoulou C, El-Mowafy AM, Barlow RS, Catravas JD, Snead C, Carrier GO, Zhu S, Yu X. Endothelium-independent effect of estrogen on Ca(2+)-activated K(+) channels in human coronary artery smooth muscle cells.  Cardiovasc Res. 2002;  53 650-661
• 60 Wu FC, von Eckardstein A. Androgens and coronary artery disease.  Endocr Rev. 2003;  24 183-217
• 61 Yildiz O, Cicek S, Ay I, Demirkilic U, Tuncer M. Hypertension increases the contractions to sumatriptan in the human internal mammary artery.  Ann Thorac Surg. 1996;  62 1392-1395
• 62 Yildiz O, Cicek S, Ay I, Tatar H, Tuncer M. 5-HT1-like receptor-mediated contraction in the human internal mammary artery.  J Cardiovasc Pharmacol. 1996;  28 6-10
• 63 Yildiz O, Nacitarhan C, Seyrek M. Potassium channels in the vasodilating action of levosimendan on the human umbilical artery.  J Soc Gynecol Investig. 2006a;  13 312-315
• 64 Yildiz O, Seyrek M, Gul H, Un I, Yildirim V, Ozal E, Uzun M, Bolu E. Testosterone relaxes human internal mammary artery in vitro.  J Cardiovasc Pharmacol. 2005;  45 580-585
• 65 Yildiz O, Seyrek M, Un I, Gul H, Candemir G, Yildirim V. The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery.  J Cardiovasc Pharmacol. 2005;  45 4-7
• 66 Yildiz O, Seyrek M, Yildirim V, Demirkilic U, Nacitarhan C. Potassium channel-related relaxation by levosimendan in the human internal mammary artery.  Ann Thorac Surg. 2006b;  81 1715-1719
• 67 Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitiveK+ channel in rat arterial myocytes.  Eur J Pharmacol. 1997;  333 249-259
• 68 Yokoshiki H, Sperelakis N. Vasodilating mechanisms of levosimendan.  Cardiovasc Drugs Ther. 2003;  17 111-113
• 69 Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta.  Circulation. 1995;  91 1154-1160

Correspondence